Artificial Intelligence for Drug Discovery and Development Market Size, Share & Trends Analysis Report By Application (Drug optimisation and repurposing, Preclinical testing, Others), By Therapeutic Area (Oncology, Neurodegenerative Diseases, Infectious Disease, Others), By End Use (Pharmaceutical & Biotechnology, CRO, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: December 16, 2025 | Author: Debashree B | Format: | Report Code: SR2538DR | Pages: 110

Market Segmentation

  1. Artificial Intelligence for Drug Discovery and Development Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Drug optimisation and repurposing
    2. Preclinical testing
    3. Others
  2. Artificial Intelligence for Drug Discovery and Development Market, By Therapeutic Area 2022-2034 (USD MILLION/ Units)
    1. Oncology
    2. Neurodegenerative Diseases
    3. Infectious Disease
    4. Others
  3. Artificial Intelligence for Drug Discovery and Development Market, By End Use 2022-2034 (USD MILLION/ Units)
    1. Pharmaceutical & Biotechnology
    2. CRO
    3. Others
  4. Regional Artificial Intelligence for Drug Discovery and Development Market
    1. North America
      1. North America Artificial Intelligence for Drug Discovery and Development Market By Application 2022-2034 (USD MILLION/ Units)
        1. Drug optimisation and repurposing
        2. Preclinical testing
        3. Others
      2. North America Artificial Intelligence for Drug Discovery and Development Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Neurodegenerative Diseases
        3. Infectious Disease
        4. Others
      3. North America Artificial Intelligence for Drug Discovery and Development Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology
        2. CRO
        3. Others
      4. U.S. Artificial Intelligence for Drug Discovery and Development Market
        1. U.S. Artificial Intelligence for Drug Discovery and Development Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug optimisation and repurposing
          2. Preclinical testing
          3. Others
        2. U.S. Artificial Intelligence for Drug Discovery and Development Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Neurodegenerative Diseases
          3. Infectious Disease
          4. Others
        3. U.S. Artificial Intelligence for Drug Discovery and Development Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology
          2. CRO
          3. Others
      5. Canada Artificial Intelligence for Drug Discovery and Development Market
        1. Canada Artificial Intelligence for Drug Discovery and Development Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug optimisation and repurposing
          2. Preclinical testing
          3. Others
        2. Canada Artificial Intelligence for Drug Discovery and Development Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Neurodegenerative Diseases
          3. Infectious Disease
          4. Others
        3. Canada Artificial Intelligence for Drug Discovery and Development Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology
          2. CRO
          3. Others
    2. Europe
      1. Europe Artificial Intelligence for Drug Discovery and Development Market By Application 2022-2034 (USD MILLION/ Units)
        1. Drug optimisation and repurposing
        2. Preclinical testing
        3. Others
      2. Europe Artificial Intelligence for Drug Discovery and Development Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Neurodegenerative Diseases
        3. Infectious Disease
        4. Others
      3. Europe Artificial Intelligence for Drug Discovery and Development Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology
        2. CRO
        3. Others
      4. U.K. Artificial Intelligence for Drug Discovery and Development Market
        1. U.K. Artificial Intelligence for Drug Discovery and Development Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug optimisation and repurposing
          2. Preclinical testing
          3. Others
        2. U.K. Artificial Intelligence for Drug Discovery and Development Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Neurodegenerative Diseases
          3. Infectious Disease
          4. Others
        3. U.K. Artificial Intelligence for Drug Discovery and Development Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology
          2. CRO
          3. Others
      5. Germany Artificial Intelligence for Drug Discovery and Development Market
        1. Germany Artificial Intelligence for Drug Discovery and Development Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug optimisation and repurposing
          2. Preclinical testing
          3. Others
        2. Germany Artificial Intelligence for Drug Discovery and Development Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Neurodegenerative Diseases
          3. Infectious Disease
          4. Others
        3. Germany Artificial Intelligence for Drug Discovery and Development Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology
          2. CRO
          3. Others
      6. France Artificial Intelligence for Drug Discovery and Development Market
        1. France Artificial Intelligence for Drug Discovery and Development Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug optimisation and repurposing
          2. Preclinical testing
          3. Others
        2. France Artificial Intelligence for Drug Discovery and Development Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Neurodegenerative Diseases
          3. Infectious Disease
          4. Others
        3. France Artificial Intelligence for Drug Discovery and Development Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology
          2. CRO
          3. Others
      7. Spain Artificial Intelligence for Drug Discovery and Development Market
        1. Spain Artificial Intelligence for Drug Discovery and Development Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug optimisation and repurposing
          2. Preclinical testing
          3. Others
        2. Spain Artificial Intelligence for Drug Discovery and Development Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Neurodegenerative Diseases
          3. Infectious Disease
          4. Others
        3. Spain Artificial Intelligence for Drug Discovery and Development Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology
          2. CRO
          3. Others
      8. Italy Artificial Intelligence for Drug Discovery and Development Market
        1. Italy Artificial Intelligence for Drug Discovery and Development Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug optimisation and repurposing
          2. Preclinical testing
          3. Others
        2. Italy Artificial Intelligence for Drug Discovery and Development Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Neurodegenerative Diseases
          3. Infectious Disease
          4. Others
        3. Italy Artificial Intelligence for Drug Discovery and Development Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology
          2. CRO
          3. Others
      9. Russia Artificial Intelligence for Drug Discovery and Development Market
        1. Russia Artificial Intelligence for Drug Discovery and Development Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug optimisation and repurposing
          2. Preclinical testing
          3. Others
        2. Russia Artificial Intelligence for Drug Discovery and Development Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Neurodegenerative Diseases
          3. Infectious Disease
          4. Others
        3. Russia Artificial Intelligence for Drug Discovery and Development Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology
          2. CRO
          3. Others
      10. Nordic Artificial Intelligence for Drug Discovery and Development Market
        1. Nordic Artificial Intelligence for Drug Discovery and Development Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug optimisation and repurposing
          2. Preclinical testing
          3. Others
        2. Nordic Artificial Intelligence for Drug Discovery and Development Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Neurodegenerative Diseases
          3. Infectious Disease
          4. Others
        3. Nordic Artificial Intelligence for Drug Discovery and Development Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology
          2. CRO
          3. Others
      11. Benelux Artificial Intelligence for Drug Discovery and Development Market
        1. Benelux Artificial Intelligence for Drug Discovery and Development Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug optimisation and repurposing
          2. Preclinical testing
          3. Others
        2. Benelux Artificial Intelligence for Drug Discovery and Development Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Neurodegenerative Diseases
          3. Infectious Disease
          4. Others
        3. Benelux Artificial Intelligence for Drug Discovery and Development Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology
          2. CRO
          3. Others
      12. Rest of Europe Artificial Intelligence for Drug Discovery and Development Market
        1. Rest of Europe Artificial Intelligence for Drug Discovery and Development Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug optimisation and repurposing
          2. Preclinical testing
          3. Others
        2. Rest of Europe Artificial Intelligence for Drug Discovery and Development Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Neurodegenerative Diseases
          3. Infectious Disease
          4. Others
        3. Rest of Europe Artificial Intelligence for Drug Discovery and Development Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology
          2. CRO
          3. Others
    3. APAC
      1. APAC Artificial Intelligence for Drug Discovery and Development Market By Application 2022-2034 (USD MILLION/ Units)
        1. Drug optimisation and repurposing
        2. Preclinical testing
        3. Others
      2. APAC Artificial Intelligence for Drug Discovery and Development Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Neurodegenerative Diseases
        3. Infectious Disease
        4. Others
      3. APAC Artificial Intelligence for Drug Discovery and Development Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology
        2. CRO
        3. Others
      4. China Artificial Intelligence for Drug Discovery and Development Market
        1. China Artificial Intelligence for Drug Discovery and Development Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug optimisation and repurposing
          2. Preclinical testing
          3. Others
        2. China Artificial Intelligence for Drug Discovery and Development Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Neurodegenerative Diseases
          3. Infectious Disease
          4. Others
        3. China Artificial Intelligence for Drug Discovery and Development Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology
          2. CRO
          3. Others
      5. Korea Artificial Intelligence for Drug Discovery and Development Market
        1. Korea Artificial Intelligence for Drug Discovery and Development Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug optimisation and repurposing
          2. Preclinical testing
          3. Others
        2. Korea Artificial Intelligence for Drug Discovery and Development Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Neurodegenerative Diseases
          3. Infectious Disease
          4. Others
        3. Korea Artificial Intelligence for Drug Discovery and Development Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology
          2. CRO
          3. Others
      6. Japan Artificial Intelligence for Drug Discovery and Development Market
        1. Japan Artificial Intelligence for Drug Discovery and Development Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug optimisation and repurposing
          2. Preclinical testing
          3. Others
        2. Japan Artificial Intelligence for Drug Discovery and Development Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Neurodegenerative Diseases
          3. Infectious Disease
          4. Others
        3. Japan Artificial Intelligence for Drug Discovery and Development Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology
          2. CRO
          3. Others
      7. India Artificial Intelligence for Drug Discovery and Development Market
        1. India Artificial Intelligence for Drug Discovery and Development Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug optimisation and repurposing
          2. Preclinical testing
          3. Others
        2. India Artificial Intelligence for Drug Discovery and Development Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Neurodegenerative Diseases
          3. Infectious Disease
          4. Others
        3. India Artificial Intelligence for Drug Discovery and Development Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology
          2. CRO
          3. Others
      8. Australia Artificial Intelligence for Drug Discovery and Development Market
        1. Australia Artificial Intelligence for Drug Discovery and Development Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug optimisation and repurposing
          2. Preclinical testing
          3. Others
        2. Australia Artificial Intelligence for Drug Discovery and Development Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Neurodegenerative Diseases
          3. Infectious Disease
          4. Others
        3. Australia Artificial Intelligence for Drug Discovery and Development Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology
          2. CRO
          3. Others
      9. Taiwan Artificial Intelligence for Drug Discovery and Development Market
        1. Taiwan Artificial Intelligence for Drug Discovery and Development Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug optimisation and repurposing
          2. Preclinical testing
          3. Others
        2. Taiwan Artificial Intelligence for Drug Discovery and Development Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Neurodegenerative Diseases
          3. Infectious Disease
          4. Others
        3. Taiwan Artificial Intelligence for Drug Discovery and Development Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology
          2. CRO
          3. Others
      10. South East Asia Artificial Intelligence for Drug Discovery and Development Market
        1. South East Asia Artificial Intelligence for Drug Discovery and Development Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug optimisation and repurposing
          2. Preclinical testing
          3. Others
        2. South East Asia Artificial Intelligence for Drug Discovery and Development Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Neurodegenerative Diseases
          3. Infectious Disease
          4. Others
        3. South East Asia Artificial Intelligence for Drug Discovery and Development Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology
          2. CRO
          3. Others
      11. Rest of Asia-Pacific Artificial Intelligence for Drug Discovery and Development Market
        1. Rest of Asia-Pacific Artificial Intelligence for Drug Discovery and Development Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug optimisation and repurposing
          2. Preclinical testing
          3. Others
        2. Rest of Asia-Pacific Artificial Intelligence for Drug Discovery and Development Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Neurodegenerative Diseases
          3. Infectious Disease
          4. Others
        3. Rest of Asia-Pacific Artificial Intelligence for Drug Discovery and Development Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology
          2. CRO
          3. Others
    4. Middle East and Africa
      1. Middle East and Africa Artificial Intelligence for Drug Discovery and Development Market By Application 2022-2034 (USD MILLION/ Units)
        1. Drug optimisation and repurposing
        2. Preclinical testing
        3. Others
      2. Middle East and Africa Artificial Intelligence for Drug Discovery and Development Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Neurodegenerative Diseases
        3. Infectious Disease
        4. Others
      3. Middle East and Africa Artificial Intelligence for Drug Discovery and Development Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology
        2. CRO
        3. Others
      4. UAE Artificial Intelligence for Drug Discovery and Development Market
        1. UAE Artificial Intelligence for Drug Discovery and Development Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug optimisation and repurposing
          2. Preclinical testing
          3. Others
        2. UAE Artificial Intelligence for Drug Discovery and Development Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Neurodegenerative Diseases
          3. Infectious Disease
          4. Others
        3. UAE Artificial Intelligence for Drug Discovery and Development Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology
          2. CRO
          3. Others
      5. Turkey Artificial Intelligence for Drug Discovery and Development Market
        1. Turkey Artificial Intelligence for Drug Discovery and Development Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug optimisation and repurposing
          2. Preclinical testing
          3. Others
        2. Turkey Artificial Intelligence for Drug Discovery and Development Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Neurodegenerative Diseases
          3. Infectious Disease
          4. Others
        3. Turkey Artificial Intelligence for Drug Discovery and Development Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology
          2. CRO
          3. Others
      6. Saudi Arabia Artificial Intelligence for Drug Discovery and Development Market
        1. Saudi Arabia Artificial Intelligence for Drug Discovery and Development Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug optimisation and repurposing
          2. Preclinical testing
          3. Others
        2. Saudi Arabia Artificial Intelligence for Drug Discovery and Development Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Neurodegenerative Diseases
          3. Infectious Disease
          4. Others
        3. Saudi Arabia Artificial Intelligence for Drug Discovery and Development Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology
          2. CRO
          3. Others
      7. South Africa Artificial Intelligence for Drug Discovery and Development Market
        1. South Africa Artificial Intelligence for Drug Discovery and Development Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug optimisation and repurposing
          2. Preclinical testing
          3. Others
        2. South Africa Artificial Intelligence for Drug Discovery and Development Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Neurodegenerative Diseases
          3. Infectious Disease
          4. Others
        3. South Africa Artificial Intelligence for Drug Discovery and Development Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology
          2. CRO
          3. Others
      8. Egypt Artificial Intelligence for Drug Discovery and Development Market
        1. Egypt Artificial Intelligence for Drug Discovery and Development Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug optimisation and repurposing
          2. Preclinical testing
          3. Others
        2. Egypt Artificial Intelligence for Drug Discovery and Development Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Neurodegenerative Diseases
          3. Infectious Disease
          4. Others
        3. Egypt Artificial Intelligence for Drug Discovery and Development Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology
          2. CRO
          3. Others
      9. Nigeria Artificial Intelligence for Drug Discovery and Development Market
        1. Nigeria Artificial Intelligence for Drug Discovery and Development Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug optimisation and repurposing
          2. Preclinical testing
          3. Others
        2. Nigeria Artificial Intelligence for Drug Discovery and Development Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Neurodegenerative Diseases
          3. Infectious Disease
          4. Others
        3. Nigeria Artificial Intelligence for Drug Discovery and Development Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology
          2. CRO
          3. Others
      10. Rest of MEA Artificial Intelligence for Drug Discovery and Development Market
        1. Rest of MEA Artificial Intelligence for Drug Discovery and Development Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug optimisation and repurposing
          2. Preclinical testing
          3. Others
        2. Rest of MEA Artificial Intelligence for Drug Discovery and Development Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Neurodegenerative Diseases
          3. Infectious Disease
          4. Others
        3. Rest of MEA Artificial Intelligence for Drug Discovery and Development Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology
          2. CRO
          3. Others
    5. LATAM
      1. LATAM Artificial Intelligence for Drug Discovery and Development Market By Application 2022-2034 (USD MILLION/ Units)
        1. Drug optimisation and repurposing
        2. Preclinical testing
        3. Others
      2. LATAM Artificial Intelligence for Drug Discovery and Development Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Neurodegenerative Diseases
        3. Infectious Disease
        4. Others
      3. LATAM Artificial Intelligence for Drug Discovery and Development Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology
        2. CRO
        3. Others
      4. Brazil Artificial Intelligence for Drug Discovery and Development Market
        1. Brazil Artificial Intelligence for Drug Discovery and Development Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug optimisation and repurposing
          2. Preclinical testing
          3. Others
        2. Brazil Artificial Intelligence for Drug Discovery and Development Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Neurodegenerative Diseases
          3. Infectious Disease
          4. Others
        3. Brazil Artificial Intelligence for Drug Discovery and Development Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology
          2. CRO
          3. Others
      5. Mexico Artificial Intelligence for Drug Discovery and Development Market
        1. Mexico Artificial Intelligence for Drug Discovery and Development Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug optimisation and repurposing
          2. Preclinical testing
          3. Others
        2. Mexico Artificial Intelligence for Drug Discovery and Development Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Neurodegenerative Diseases
          3. Infectious Disease
          4. Others
        3. Mexico Artificial Intelligence for Drug Discovery and Development Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology
          2. CRO
          3. Others
      6. Argentina Artificial Intelligence for Drug Discovery and Development Market
        1. Argentina Artificial Intelligence for Drug Discovery and Development Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug optimisation and repurposing
          2. Preclinical testing
          3. Others
        2. Argentina Artificial Intelligence for Drug Discovery and Development Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Neurodegenerative Diseases
          3. Infectious Disease
          4. Others
        3. Argentina Artificial Intelligence for Drug Discovery and Development Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology
          2. CRO
          3. Others
      7. Chile Artificial Intelligence for Drug Discovery and Development Market
        1. Chile Artificial Intelligence for Drug Discovery and Development Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug optimisation and repurposing
          2. Preclinical testing
          3. Others
        2. Chile Artificial Intelligence for Drug Discovery and Development Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Neurodegenerative Diseases
          3. Infectious Disease
          4. Others
        3. Chile Artificial Intelligence for Drug Discovery and Development Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology
          2. CRO
          3. Others
      8. Colombia Artificial Intelligence for Drug Discovery and Development Market
        1. Colombia Artificial Intelligence for Drug Discovery and Development Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug optimisation and repurposing
          2. Preclinical testing
          3. Others
        2. Colombia Artificial Intelligence for Drug Discovery and Development Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Neurodegenerative Diseases
          3. Infectious Disease
          4. Others
        3. Colombia Artificial Intelligence for Drug Discovery and Development Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology
          2. CRO
          3. Others
      9. Rest of LATAM Artificial Intelligence for Drug Discovery and Development Market
        1. Rest of LATAM Artificial Intelligence for Drug Discovery and Development Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug optimisation and repurposing
          2. Preclinical testing
          3. Others
        2. Rest of LATAM Artificial Intelligence for Drug Discovery and Development Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Neurodegenerative Diseases
          3. Infectious Disease
          4. Others
        3. Rest of LATAM Artificial Intelligence for Drug Discovery and Development Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology
          2. CRO
          3. Others
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on: